Palisade Bio Provides Business Outlook And Highlights Expected Near-Term Pipeline Advancements
Palisade Bio (NASDAQ:PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications, today provided a business outlook and outlined its
4 Penny Stocks Insiders Are Buying: Heritage Global, Palisade Bio And More
US crude oil futures traded lower this morning on Friday. Investors, meanwhile, focused on some notable insider trades.
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
66 Biggest Movers From Yesterday
Gainers
JX Luxventure Limited (NASDAQ: LLL) shares jumped 119.5% to settle at $4.39 on Tuesday after the company announced it signed a $60 million sales agreement.
FDA Gives Green Signal For Palisade Bio’s LB1148 Phase 3 Study
Palisade Bio Inc (NASDAQ: PALI) has
75 Biggest Movers From Yesterday
Gainers
NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) shares jumped 299.4% to close at $6.23 on Monday as the company received clearance from the FDA to initiate a pharmacokinetic study of PrimeC in healthy adult subjects.
Stocks That Hit 52-Week Lows On Monday
During Monday's session, 39 stocks hit new 52-week lows.
